Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Update

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the recipient of a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 2,205 shares, a drop of 61.7% from the July 30th total of 5,764 shares. Based on an average trading volume of 18,091 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Nihon Kohden Trading Down 2.6%

Nihon Kohden stock opened at $9.26 on Friday. The stock has a fifty day moving average price of $9.33 and a 200 day moving average price of $9.53. Nihon Kohden has a 52 week low of $8.12 and a 52 week high of $14.21. The firm has a market capitalization of $1.56 billion, a P/E ratio of 16.84 and a beta of 0.37.

Nihon Kohden (OTCMKTS:NHNKY) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). The business had revenue of $297.47 million during the quarter, compared to analyst estimates of $299.98 million. Nihon Kohden had a return on equity of 9.08% and a net margin of 5.90%. As a group, equities analysts predict that Nihon Kohden will post 0.6 EPS for the current year.

Wall Street Analyst Weigh In

Separately, UBS Group cut shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 12th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.